Abstract:
An organometallic compound represented by Formula 1: wherein, in Formula 1, groups and variables are the same as described in the specification.
Abstract:
A condensed cyclic compound represented by Formulae 1A or 1B: wherein in Formulae 1A and 1 B, groups, rings, substituents, and variables are defined in the detailed description.
Abstract:
A chemical compound is provided having a structure that includes at least one donor moiety covalently bonded to at least one acceptor moiety. For example, the compound may include an indolocarbazole moiety covalently bonded to at least one furylpyridine moiety. The compound may exhibit thermally activated delayed fluorescence and an accompanying ΔEST of no greater than about 0.25 eV. The compound finds use in OLED display technology.
Abstract:
A display device includes a plurality of organic light-emitting diode (OLED) pixels on a substrate, and a plurality of light-emitting diode (LED) pixels between the plurality of OLED pixels on the substrate, the plurality of LED pixels on a same plane as the plurality of OLED pixels.
Abstract:
An organometallic compound represented by Formula 1: M(L1)n1(L2)n2, Formula 1 wherein M is selected from iridium (Ir), platinum (Pt), osmium (Os), titanium (Ti), zirconium (Zr), hafnium (Hf), europium (Eu), terbium (Tb), thulium (Tm), and rhodium (Rd), and wherein L1 is a ligand represented by Formula 2A and L2 is a ligand represented by Formula 2B, and wherein L1 and L2 in Formula 1 are different from each other,
Abstract:
An organometallic compound is represented by Formula 1: wherein, in Formula 1, groups and variables are the same as described in the specification. The organometallic compound represented by Formula 1 provides high photoluminescent efficiency and is useful in organic light-emitting devices or as a diagnostic composition (e.g., various applications including a diagnosis kit a diagnosis reagent, a biosensor, or a biomarker).
Abstract:
An organometallic compound represented by Formula 1: M1(L1)n1(L2)n2 Formula 1 wherein, M1 is a transition metal, L1 is a ligand represented by Formula 1A, L2 is a ligand represented by Formula 1B, and n1 and n2 are each independently 1 or 2, wherein X43 is C(R43), N, or C bonded to Y3; X44 is C(R44), N, or C bonded to Y2 or Y3; X45 is C(R45), N, or C bonded to Y2 or Y3; X46 is C(R46), N, or C bonded to Y2, wherein i) X43 is C bonded to Y3, and X44 is C bonded to Y2; ii) X44 is C bonded to Y3, and X45 is C bonded to Y2; or iii) X45 is C bonded to Y3, and X46 is C bonded to Y2, and the remaining substituents are as described herein.
Abstract:
An organometallic compound represented by Formula 1: M1(L1)n1(L2)n2 Formula 1 wherein M1 is a transition metal, L1 is a ligand represented by Formula 1A, L2 is a ligand represented by Formula 1B, and n1 and n2 are each independently 1 or 2, with the proviso that i) X45 is C(R45), X46 is C(R46), and R45 and R46 are bonded to each other to form a group represented by Formula 2, ii) X46 is C(R46), X47 is C(R47), and R46 and R47 are bonded to each other to form a group represented by Formula 2, or iii) X47 is C(R47), X48 is C(R48), and R47 and R48 are bonded to each other to form a group represented by Formula 2, ring CY42 and ring CY5 are condensed with each other, and the remaining substituent groups are as defined herein.